{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T14:44:54Z","timestamp":1786718694282,"version":"build-2736575974"},"reference-count":9,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asian J Androl"],"published-print":{"date-parts":[[2018]]},"DOI":"10.4103\/aja.aja_7_18","type":"journal-article","created":{"date-parts":[[2018,2,16]],"date-time":"2018-02-16T00:25:01Z","timestamp":1518740701000},"page":"152","source":"Crossref","is-referenced-by-count":4,"title":["Conclusions about testosterone therapy and cardiovascular risk"],"prefix":"10.4103","volume":"20","author":[{"given":"BradleyD","family":"Anawalt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BuB","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1008-682X.225647-1","first-page":"115\u20139","volume-title":"Endogenous testosterone and mortality risk","author":"Meyer","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.225647-2","first-page":"109\u201314","volume-title":"Testosterone and its metabolites: differential associations with cardiovascular and cerebrovascular events in men","author":"Yeap","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.225647-3","first-page":"138\u201344","volume-title":"Testosterone treatment and cardiovascular events in prescription database studies","author":"Shores","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.225647-4","first-page":"120\u201330","volume-title":"Randomized controlled trials \u2013 mechanistic studies of testosterone and the cardiovascular system","author":"Jones","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.225647-5","first-page":"131\u20137","volume-title":"Trials of testosterone replacement reporting cardiovascular adverse events","author":"Gagliano-Juca","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.225647-6","first-page":"611\u201324","volume-title":"Effects of testosterone treatment in older men","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"key-10.4103\/1008-682X.225647-7","first-page":"708\u201316","volume-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","author":"Budoff","year":"2018","journal-title":"JAMA"},{"key":"key-10.4103\/1008-682X.225647-8","first-page":"145\u20138","volume-title":"Would male hormonal contraceptives affect cardiovascular risk?","author":"Zitzmann","year":"2018","journal-title":"Asian J Androl"},{"key":"key-10.4103\/1008-682X.225647-9","first-page":"149\u201351","volume-title":"Testosterone replacement therapy: dilemmas and challenges in China and Asia","author":"An","year":"2018","journal-title":"Asian J Androl"}],"container-title":["Asian Journal of Andrology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:38:31Z","timestamp":1786714711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/aja.aja_7_18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018]]}},"alternative-id":["225647"],"URL":"https:\/\/doi.org\/10.4103\/aja.aja_7_18","relation":{},"ISSN":["1008-682X"],"issn-type":[{"value":"1008-682X","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]}}}